Enzymes: The Tiny Nano‑Machines Powering Modern Industry

Take a bite of bread, and you will taste sweetness in just 30 seconds. No sugar has been added to the bread. Instead, a substance in your saliva breaks down starch. Within one bite of bread, it cleaves millions of starch molecules. Each broken‑down molecule releases a glucose unit, and the sweetness you taste is produced right inside your mouth.

Factories also use this very same substance to replace 400‑degree‑Celsius reaction furnaces. Sold in boxes for 15 currency units on supermarket shelves, its name is enzyme.

Almost everyone has heard of enzymes from biology class: amylase in saliva, protease in the stomach. Yet most people are unaware that nearly all industrial goods we interact with daily rely heavily on enzymes — not enzymes from our bodies, but those deployed at scale inside factories.

Why can laundry detergent remove hot‑pot grease? It is not only surfactants doing the work. Lipase splits oil molecules piece by piece into water‑soluble fragments.

Why can bread stay soft for three days without hardening? It is not preservatives, but maltogenic amylase. It keeps working inside dough, re‑breaking down starch that would otherwise turn stiff.

What gives beer its characteristic flavour? Thousands of years ago, humans brewed beer using enzymes naturally produced by barley. Modern breweries add exogenous enzymes instead. These enzymes are hundreds of times more efficient than barley‑sourced ones, delivering identical craftsmanship and flavour yet speeding up production dozens‑fold.

Such exogenous enzymes are not extracted from plants or animals. They are manufactured via microbial fermentation. Inside factory rows of multi‑ton stainless‑steel fermenters, bacteria or fungal strains are fed corn steep liquor and glucose. They multiply inside the tanks and secrete enzymes outward. After fermentation, microbial cells are filtered out. The remaining liquid goes through purification, concentration and drying to yield white powder — enzyme preparations. One gram of this powder may contain trillions of enzyme molecules. Pour it into laundry detergent, knead it into dough, or mix it into animal feed, and these molecules spring into action.

The industry traces its origin back to 1941. The Nordic company Novo Nordisk extracted trypsin from pig pancreas for leather tanning. This marked humanity’s first industrial‑scale application of enzymes. Back then, producing one gram of enzyme required processing dozens of kilograms of pig pancreas. Sky‑high costs limited its use only to premium products.

A real turning point arrived with mature microbial‑fermentation technology. The company, later renamed Novozymes, realised: rather than slaughtering pigs for enzymes, it made far more sense to cultivate microbes to produce them. A single fermenter batch could yield enzymes equivalent to thousands of pigs.

The industry’s core moat lies not in patents, but microbial strains. Every enzyme‑producing microbe is the result of decades‑long screening and modification. Novozymes maintains a massive strain library. Developing one high‑performance enzyme‑producing strain can take years. Competitors may build fermenters and source raw materials, yet without superior strains, their enzymes suffer drastically lower activity.

Eighty years on, Novozymes has merged with another Nordic firm, controlling over 30% of the global industrial‑enzyme market. The top five companies together capture more than 60% of the market share, making a small Nordic nation the dominant player in global enzyme‑preparation industries.

In the past, humans sourced enzymes through natural screening: heat‑resistant microbes from hot‑spring geothermal sites, salt‑tolerant strains from saline‑alkali land, and cellulose‑degrading bacteria from cattle rumens. We could only obtain enzymes nature had already evolved.

In 2018, the Nobel Prize in Chemistry was awarded to Frances Arnold. She invented directed evolution of enzymes: target enzymes are placed within mutation systems for rapid evolution. In merely weeks, they achieve evolutionary leaps that would take nature millions of years.

Later, artificial intelligence directly designs enzymes’ protein amino‑acid sequences based on target chemical reactions. Tell AI which plastic you want degraded or which drug you wish to synthesise, and it designs brand‑new enzymes that have never existed in nature.

This shifts the industry’s competitive moat. Previously, whoever owned the best microbial strains held sway. In the future, whoever owns superior AI models can design new enzymes within weeks, bypassing decades‑worth of accumulated strain resources from predecessors. The 80‑year‑old industry fortress built by Nordic enterprises through strain libraries is being undermined by AI.

Today enzymes are best‑known for cleaning shirt collars. Tomorrow they may convert plastic bottles back into industrial feedstock, turn agricultural straw waste into jet fuel, or design pharmaceuticals activated exclusively inside human livers. All these applications have already been proven in laboratory settings.

Starting from crude pig‑pancreas extracts in 1941, humanity has spent more than 80 years transforming enzymes from slaughter‑house waste into editable nano‑machines.